| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9ac3d1a365829a0effbf0e16e7b1b8e2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D305-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4703
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-083
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-061 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08 |
| filingDate |
2021-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a269763c59bbe961048865a69c2a5d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8eeb102fb99d73474a718d9c7cd18780
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbf143d44c7e606b2aa5b9bd70d60fa3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34822d276ef857ec5dc9802b40be0e2e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f69e3c51f3c4be970f5180080430a935
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd45d1634bcb025ae8a7fcf44bd3d326 |
| publicationDate |
2022-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2022356209-A1 |
| titleOfInvention |
Peptide compounds and peptide conjugates for the treatment of cancer through receptor-mediated chemotherapy |
| abstract |
The present disclosure relates to peptide compounds and conjugate compounds, processes, methods and uses thereof for treating cancer. For example, the compounds can comprise compounds of formula n n n n n n n n n n X 1 X 2 X 3 X 4 X 5 GVX 6 AKAGVX 7 NX 8 FKSESY n (I) n (SEQ ID NO: 1) n n n n (X 9 ) n GVX 10 AKAGVX 11 NX 12 FKSESY n (II) n (SEQ ID NO: 2) n n n n YKX 13 LRRX 14 APRWDX 15 PLRDPALRX 16 X 17 L n (III) n (SEQ ID NO: 3) n n n n YKX 18 LRR(X 19 ) n PLRDPALRX 20 X 21 L n (IV) n (SEQ ID NO: 4) n n n n IKLSGGVQAKAGVINMDKSESM n (V) n (SEQ ID NO: 5) n n n n IKLSGGVQAKAGVINMFKSESY n (VI) n (SEQ ID NO: 6) n n n n IKLSGGVQAKAGVINMFKSESYK n (VII) n (SEQ ID NO: 7) n n n n GVQAKAGVINMFKSESY n (VIII) n (SEQ ID NO: 8) n n n n GVRAKAGVRNMFKSESY n (IX) n (SEQ ID NO: 9) n n n n GVRAKAGVRN(Nle)FKSESY n (X) n (SEQ ID NO: 10) n n n n YKSLRRKAPRWDAPLRDPALRQLL n (XI) n (SEQ ID NO: 11) n n n n YKSLRRKAPRWDAYLRDPALRQLL n (XII) n (SEQ ID NO: 12) n n n n YKSLRRKAPRWDAYLRDPALRPLL n (XIII) n (SEQ ID NO: 13) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n wherein X 1 to X 21 and n can have various different values n and wherein at least one protecting group and/or at least one labelling agent is optionally connected to said peptide compound at an N- and/or C-terminal end. |
| priorityDate |
2015-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |